Considering that several HPSE inhibitors are currently undergoing clinical trials and have demonstrated anti-tumor efficacy and few side effects, the results of this study strongly encourage a possible future use of these drugs in the treatment of liver fibrosis as well. The gene discussed is HPSE; the disease is neoplasm.